Multidisciplinary Hospital for Active Treatment (MHAT) Evropa OOD
- Address
- lock Available on a paid plan
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The Department of gastroenterology at Multidisciplinary Hospital for Active Treatment (MHAT) Evropa OOD is conducting early‑phase studies that focus on rare inherited disorders such as Adult polyglucosan body disease.
- Safety and tolerability evaluation in healthy volunteers
- Pharmacokinetic profiling of investigational compounds
- Assessment of disease‑specific biomarkers
These efforts aim to generate foundational data that could support future therapeutic options for patients with hereditary metabolic conditions.
Pathological Conditions, Signs and Symptoms
In the same department, researchers are performing comparative studies to confirm the equivalence of pain‑management products, notably transdermal therapeutic systems delivering fentanyl.
- Bioequivalence testing in controlled settings
- Evaluation of systemic exposure and safety
- Regulatory compliance for generic approval
By establishing comparable performance, the trials help ensure reliable and affordable analgesic options for patients across Europe.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Multidisciplinary Hospital for Active Treatment (MHAT) Evropa OOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Bioequivalence of two 100 µg/h transdermal fentanyl patches in healthy volunteers | CCDRD Cooperative Clinical Drug Research and Development AG, Lavipharm S.A. | Phase I | Not Yet Recruiting | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.